about
Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 OncoproteinsHuman Papillomaviruses; Epithelial Tropisms, and the Development of NeoplasiaConcepts of papillomavirus entry into host cellsThe human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.Papillomaviruses: a systematic review.hrHPV E5 oncoprotein: immune evasion and related immunotherapies.Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteinsConcurrence of Iridovirus, Polyomavirus, and a Unique Member of a New Group of Fish Papillomaviruses in Lymphocystis Disease-Affected Gilthead Sea Bream.Peptidic inhibitors for in vitro pentamer formation of human papillomavirus capsid protein l1.The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membraneIdentification of a Novel Human Papillomavirus, Type HPV199, Isolated from a Nasopharynx and Anal Canal, and Complete Genomic Characterization of Papillomavirus Species Gamma-12Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.Characterization of human papillomavirus type 16 pseudovirus containing histonesThe Papillomavirus Episteme: a major update to the papillomavirus sequence databaseMolecular biology of gynecological cancer.Naturally Occurring Major and Minor Capsid Protein Variants of Human Papillomavirus 45 (HPV45): Differential Recognition by Cross-Neutralizing Antibodies Generated by HPV Vaccines.Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on CyclophilinsMolecular archeological evidence in support of the repeated loss of a papillomavirus geneThe Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies.The tetraspanin CD151 in papillomavirus infection.The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology.Functional assessment and structural basis of antibody binding to human papillomavirus capsid.Tetraspanins in infections by human cytomegalo- and papillomaviruses.Host cell restriction factors that limit transcription and replication of human papillomavirus.Human papillomavirus molecular biology.Structural features of glycan recognition among viral pathogens.Oncogenic human papillomaviruses.Current status and future prospects for human papillomavirus vaccines.The VPS4 component of the ESCRT machinery plays an essential role in HPV infectious entry and capsid disassembly.The CD63-Syntenin-1 Complex Controls Post-Endocytic Trafficking of Oncogenic Human Papillomaviruses.Rodent Papillomaviruses.Felis catus papillomavirus type-2 but not type-1 is detectable and transcriptionally active in the blood of healthy cats.Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity.Human Papillomavirus 16 infection induces VAP-dependent endosomal tubulation.Superinfection Exclusion between Two High-Risk Human Papillomavirus (HPV) Types During a Co-Infection.Phylogeny and polymorphism in the long control regions E6, E7, and L1 of HPV Type 56 in women from southwest China.
P2860
Q26795741-7D50BA7B-4ABC-44DD-9211-41F0B0C4513DQ26801768-6CC25E22-AF07-45B4-971B-33BF20A7F9F6Q27026900-782C6026-D35F-4F7F-940E-6BB5850DED8BQ30362003-06983BC0-B81F-4AA7-868E-13AC8C3A8DB6Q33604135-8630C07F-D944-4887-80CD-F46B475ED2A0Q33617085-F60A87BB-A4EA-462C-851C-11040B0BEF6AQ33730462-891B92E7-3508-47F3-9245-E2897B2A2387Q34492140-8DDB988B-28F1-428F-A42F-9379062B143FQ34534769-E9E8D932-AB89-46B3-A91B-487D1320E9B0Q35379036-572492DD-02C2-481A-85D1-B3EA28E3CEA5Q35624920-7CED0472-69FD-42C2-9A03-70241C0692FAQ35777190-1ABAEC05-5167-48F7-B638-A474EB701EBDQ35861286-9BED74D5-B909-4F6C-A7C0-7A403E8FA4F3Q36115229-10AF920B-2B66-4AD0-BC37-D067C6F448C9Q36239822-FC854B47-B5C1-49BA-993B-5361329220F6Q36502779-B0540940-480F-412A-91EB-47E1219307EFQ36736614-3639340E-A2D2-4FE5-B7D7-9F80308A23BCQ37073350-E022A6E3-AECE-478F-BC62-4E73760C78B7Q37240005-1A7448E8-0B36-40E2-9F05-B2789535A358Q37415380-0ED85893-1BA0-4EB7-955C-910FFA5B90F2Q37526148-3811C46A-D749-4958-A691-F2016A94C9BFQ37611844-4BAFE103-E2A0-4BF1-A198-4C9247742CC5Q38254163-4E023C8C-5FFB-4837-ADD2-88D2EE238A63Q38671633-9F40C2CE-21EB-4622-95AC-650A0C60182BQ38837603-E1AD9954-C18E-467A-B0DE-3F06590E7E8BQ39013547-A680393E-B606-45FA-B131-4F2B36187E06Q39320611-DF90B83F-8CB6-4073-B287-C703238B73AEQ39357995-EAFB6F5D-602D-4300-9A9D-D0AB22F7AFD3Q40046605-46F4D70B-5BC5-4E75-AF66-9B9375D5A40DQ40056541-D6AC6B84-17CF-4AA6-A087-AE856415FF85Q40270627-756FA213-C201-43EE-A36D-7840FB33388BQ40557268-442C56E2-6857-46FE-8395-62A12B2F05FBQ46251800-B9372EC6-B337-4486-BA86-158CCEB8A994Q46271848-DA38398F-2BEF-45E2-9218-B479B7A81B14Q47363184-063FDC3F-A45D-4BC2-9E43-4884B531BD57Q47555803-2E82B04E-9A84-4759-8DB3-1A8975A0D386Q50043357-B0E98371-A914-4E11-B673-2449F4FF5B1CQ54094196-7E93834D-B787-472B-BB90-3F3021327706
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The papillomavirus major capsid protein L1.
@en
The papillomavirus major capsid protein L1.
@nl
type
label
The papillomavirus major capsid protein L1.
@en
The papillomavirus major capsid protein L1.
@nl
prefLabel
The papillomavirus major capsid protein L1.
@en
The papillomavirus major capsid protein L1.
@nl
P2860
P1433
P1476
The papillomavirus major capsid protein L1.
@en
P2093
Benes L Trus
Patricia M Day
P2860
P304
P356
10.1016/J.VIROL.2013.05.038
P407
P577
2013-06-22T00:00:00Z